# TRANSDERMAL HRT RELIEVING POSTMENOPAUSAL SYMPTOMS

> **NCT02033512** · PHASE2 · COMPLETED · sponsor: **University Potiguar** · enrollment: 66 (actual)

## Conditions studied

- Menopause

## Interventions

- **DRUG:** Transdermal Hormone Replacement Therapy
- **DRUG:** Transdermal Nanoformulation
- **DRUG:** Transdermal formulation

## Key facts

- **NCT ID:** NCT02033512
- **Lead sponsor:** University Potiguar
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2004-01
- **Final completion:** 2008-04
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2014-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02033512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02033512, "TRANSDERMAL HRT RELIEVING POSTMENOPAUSAL SYMPTOMS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02033512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*